377 related articles for article (PubMed ID: 29681195)
1. Biologics for treating axial spondyloarthritis.
Jones A; Ciurtin C; Ismajli M; Leandro M; Sengupta R; Machado PM
Expert Opin Biol Ther; 2018 Jun; 18(6):641-652. PubMed ID: 29681195
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological management of axial spondyloarthritis in adults.
Toussirot E
Expert Opin Pharmacother; 2019 Aug; 20(12):1483-1491. PubMed ID: 31095430
[No Abstract] [Full Text] [Related]
3. Certolizumab pegol for treating axial spondyloarthritis.
Desmarais J; Beier S; Deodhar A
Expert Opin Biol Ther; 2016 Aug; 16(8):1059-64. PubMed ID: 27366922
[TBL] [Abstract][Full Text] [Related]
4. Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts.
Ez-Zaitouni Z; Hilkens A; Gossec L; Berg IJ; Landewé R; Ramonda R; Dougados M; van der Heijde D; van Gaalen F
Arthritis Res Ther; 2017 May; 19(1):118. PubMed ID: 28569222
[TBL] [Abstract][Full Text] [Related]
5. Challenges of diagnosis and management of axial spondyloarthritis in North Africa and the Middle East: An expert consensus.
Hammoudeh M; Abdulaziz S; Alosaimi H; Al-Rayes H; Aldeen Sarakbi H; Baamer M; Baraliakos X; Dahou Makhloufi C; Janoudi N; Shirazy K; Sieper J; Sukhbir U
J Int Med Res; 2016 Apr; 44(2):216-30. PubMed ID: 26811411
[TBL] [Abstract][Full Text] [Related]
6. Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology.
Pedersen SJ; Maksymowych WP
Drugs; 2018 Sep; 78(14):1397-1418. PubMed ID: 30171593
[TBL] [Abstract][Full Text] [Related]
7. Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study.
Lubrano E; Perrotta FM; Marchesoni A; D'Angelo S; Ramonda R; Addimanda O; Olivieri I; Punzi L; Salvarani C
J Rheumatol; 2015 Feb; 42(2):258-63. PubMed ID: 25512483
[TBL] [Abstract][Full Text] [Related]
8. Axial spondyloarthritis.
Sieper J; Braun J; Dougados M; Baeten D
Nat Rev Dis Primers; 2015 Jul; 1():15013. PubMed ID: 27188328
[TBL] [Abstract][Full Text] [Related]
9. Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.
Akkoc N; Can G; D'Angelo S; Padula A; Olivieri I
Curr Rheumatol Rep; 2017 Feb; 19(2):8. PubMed ID: 28197884
[TBL] [Abstract][Full Text] [Related]
10. Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis.
Ceribelli A; Motta F; Vecellio M; Isailovic N; Ciccia F; Selmi C
Front Immunol; 2021; 12():622770. PubMed ID: 34149686
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study.
Andreasen RA; Kristensen LE; Ellingsen T; Christensen R; Baraliakos X; Wied J; Aalykke C; Ulstrup T; Schiøttz-Christensen B; Horn HC; Emamifar A; Duerlund B; Fischer L; Hansen IMJ
BMJ Open; 2017 Jul; 7(7):e015536. PubMed ID: 28698330
[TBL] [Abstract][Full Text] [Related]
12. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?
Mitulescu TC; Trandafir M; Dimăncescu MG; Ciuluvică RC; Popescu V; Predețeanu D; Istrate S; Voinea LM
Rom J Ophthalmol; 2018; 62(2):114-122. PubMed ID: 30206554
[TBL] [Abstract][Full Text] [Related]
13. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
[TBL] [Abstract][Full Text] [Related]
14. Emerging drugs for the treatment of axial spondyloarthritis.
Rademacher J; Poddubnyy D
Expert Opin Emerg Drugs; 2018 Mar; 23(1):83-96. PubMed ID: 29475394
[TBL] [Abstract][Full Text] [Related]
15. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
16. Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
Micheroli R; Hebeisen M; Wildi LM; Exer P; Tamborrini G; Bernhard J; Möller B; Zufferey P; Nissen MJ; Scherer A; Ciurea A;
Arthritis Res Ther; 2017 Jul; 19(1):164. PubMed ID: 28724442
[TBL] [Abstract][Full Text] [Related]
17. New developments in ankylosing spondylitis-status in 2021.
Klavdianou K; Tsiami S; Baraliakos X
Rheumatology (Oxford); 2021 Dec; 60(Suppl 6):vi29-vi37. PubMed ID: 34951921
[TBL] [Abstract][Full Text] [Related]
18. Ixekizumab: an IL-17A inhibitor for the treatment of axial Spondylarthritis.
Harrison SR; Marzo-Ortega H
Expert Rev Clin Immunol; 2021 Oct; 17(10):1059-1071. PubMed ID: 34407705
[TBL] [Abstract][Full Text] [Related]
19. Emerging drugs for the treatment of axial and peripheral spondyloarthritis.
Braun J; Kiltz U; Heldmann F; Baraliakos X
Expert Opin Emerg Drugs; 2015 Mar; 20(1):1-14. PubMed ID: 25575936
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with non-radiographic axial spondyloarthritis: an observational cohort study from Southern Sweden.
Gulfe A; Kapetanovic MC; Kristensen LE
Scand J Rheumatol; 2014; 43(6):493-7. PubMed ID: 25145283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
